Dr. Antonio Laghezza graduated summa cum laude in "Chimica e Tecnologia Farmaceutiche" at the University of Bari (Italy) in 2000. He defended his Ph.D. in Medicinal Chemistry in 2004 and worked as a research fellow until 2006 at the Medicinal Chemistry Department of the same University. He has been Lecturer since 2006. His research activities deal with the preparation and biological in vitro evaluation of new PPARs ligands, useful for the treatment of pathologies such as obesity, type II diabetes, heart failure, and cancer. He is co-author of more than 50 publications in peer-reviewed journals.